PD-1 receptor expression has also been disrupted completely via CRISPR/Cas9 resulting in augmentation of CAR T cell mediated killing of tumor cells in vitro and enhanced clearance of PDL-1 expressing tumor xenografts in vivo (129). This evidence concerns the gene CD274 and neoplasm.